Study Stopped
Due to COVID-19 disruption
A Comparison of Stryker's Tritanium Posterior Lumbar Cage and PEEK Implant
1 other identifier
interventional
4
1 country
1
Brief Summary
The purpose of this study is to compare outcomes of patients with degenerative disc disease undergo lumbar spinal fusion with Stryker's Tritanium® Posterior Lumbar Cage or the UniLIF PEEK implant.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Mar 2019
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 20, 2018
CompletedFirst Posted
Study publicly available on registry
January 25, 2019
CompletedStudy Start
First participant enrolled
March 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
April 27, 2021
CompletedResults Posted
Study results publicly available
December 15, 2021
CompletedJanuary 10, 2023
December 1, 2022
1.3 years
December 20, 2018
September 29, 2021
December 15, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Number of Participants With Fusion Success
CT and X-ray imaging will be obtained at study visits and Fusion Success will be defined by the following criteria: no lucent area around the implant; no presences of herniated disk, central stenosis, lateral recess stenosis, foraminal stenosis, facet anthropathy; no fracture of the device, graft or vertebra; visible bone formation in or about the graft material; less than 3 degrees of inter-segmental position change on flexion and extension views; presence of subsidence: a migration of more than 3mm into the adjacent vertebra; and the proportion of bridging bone visually estimated over the surface area of the joint
12 Months
Secondary Outcomes (7)
Change in Visual Analogue Scale
Baseline; 6 weeks; 3 months; 6 months; and 12 months post operation
Change in Low Back Function
Baseline; 6 weeks; 3 months; 6 months; and 12 months post operation
Change in Quality of Life: SF-36 PCS
Baseline; 6 weeks; 3 months; 6 months; and 12 months post operation.
Number of Participants That Return to Work
Baseline; 6 weeks; 3 months; 6 months; and 12 months post operation
Ambulatory Status
Baseline; 6 weeks; 3 months; 6 months; and 12 months post operation
- +2 more secondary outcomes
Study Arms (2)
Tritanium Posterior Lumbar Cage
EXPERIMENTALSurgical placement of the Tritanium Posterior Lumbar Cage
AVS PEEK UniLIF
ACTIVE COMPARATORSurgical placement of the AVS PEEK UniLIF Posterior Lumbar Cage
Interventions
Placement of Tritanium Posterior Lumbar Cage via TLIF procedure
Placement of AVS UniLIF PEEK Posterior Lumbar Cage via TLIF procedure.
Eligibility Criteria
You may qualify if:
- Subject is skeletally mature
- Subject has one or more of the following diagnoses:
- Degenerative Disc Disease (DDD) at one level or two contiguous levels from L2 to S1
- a. DDD may include up to Grade 1 spondylolisthesis at the involved level(s)
- Degenerative Scoliosis for which the interbody fusion device will be used as an adjunct to fusion
- Subject has received 6 months of non-operative therapy
- Subject understands the conditions of enrollment and is willing to sign and date the Informed Consent
- Subject agrees to comply with visit schedule and study assessments
- Provision of signed and dated informed consent form
- Subject stated willingness to comply with all study procedures and availability for the duration of the study
- Subject is in good general health as evidenced by medical history
You may not qualify if:
- Subject is obese (BMI \> 40)
- Subject is sensitive to titanium materials
- Subject has an active infection at the operative site
- Subject has marked local inflammation
- Subject has any abnormality present which affects the normal process of bone remodeling including, but not limited to, severe osteoporosis involving the spine, bone absorption, osteopenia, tumors involving the spine, active infection at the site, or certain metabolic disorders affecting osteogenesis
- Subject has any mental, trauma, or neuromuscular disorder which would create an unacceptable risk of fixation failure or complications in postoperative care
- Subject has any open wounds
- Subject is pregnant or plans to become pregnant during the course of the study
- Subject has inadequate tissue coverage over the operative site.
- Subject has an neuromuscular deficit which places an unsafe load on the device during the healing period
- Subject has any condition of senility, mental illness, or substance abuse
- Subject has any other medical or surgical condition which would preclude the potential benefit of spinal implant surgery, such as the presence of tumors, congenital abnormalities, elevation of sedimentation rate unexplained by other diseases, elevation of white blood cell count (WBC), or marked left shift in the WBC differential count.
- Subject has prior fusion at the levels to be treated
- Subject is incarcerated
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Riverside Medical Centerlead
- Stryker Spinecollaborator
Study Sites (1)
Riverside Medical Center
Kankakee, Illinois, 60901, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Cynthia Koehn, Clinical Research Nurse
- Organization
- Riverside Medical Center
Study Officials
- STUDY DIRECTOR
Lisa Zipsie
Riverside Medical Center
- PRINCIPAL INVESTIGATOR
Juan Jimenez, MD
Riverside Medical Center
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Masking Details
- Study participants will not know which posterior lumbar cage they receive.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
December 20, 2018
First Posted
January 25, 2019
Study Start
March 1, 2019
Primary Completion
June 30, 2020
Study Completion
April 27, 2021
Last Updated
January 10, 2023
Results First Posted
December 15, 2021
Record last verified: 2022-12
Data Sharing
- IPD Sharing
- Will not share